Dipharma completes second phase of CGMP expansion at its Kalamazoo site
(Dipharma), a global CDMO and leading manufacturer of Active Pharmaceutical Ingredients and advanced Intermediates, announced today the completion of the second phase of expansion of its American site, Dipharma Inc., located in Kalamazoo, MI.
- (Dipharma), a global CDMO and leading manufacturer of Active Pharmaceutical Ingredients and advanced Intermediates, announced today the completion of the second phase of expansion of its American site, Dipharma Inc., located in Kalamazoo, MI.
- The new investment provides additional CGMP, Quality Control laboratory and warehouse spaces, increasing the capability of the American site to support and expand its CDMO services.
- This expansion follows the 2020 opening of the dedicated CGMP Kilolab and QC laboratory.
- The third phase of the project is ongoing and will expand the current Kilolab by adding a second CGMP line.